FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for Effient (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc. This action confirms the approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)

Snippet

SUPPL AP for EFFIENT (PRASUGREL HYDROCHLORIDE)